RTHawk Research
MRI operating system and GUI-based design tools for research imaging applications
Company profile
Company profile
Vista AI develops intelligent software to streamline and automate MRI examinations, making gold-standard imaging universally accessible. The company's flagship product, Vista AI Scan, is an FDA-cleared automated scanning platform that simplifies the image acquisition process, enabling technologists of all skill levels to perform accurate, high-quality cardiac MRI scans with consistency and efficiency. The platform addresses critical challenges facing imaging programs including rising demand, staffing shortages, and increasing clinical complexity. By automating what once required specialist expertise, Vista AI enables healthcare organizations to expand cardiac MRI services across multiple sites with existing staff and resources. The technology has demonstrated real-world results including 26% faster scan times, 50% more scan slots, and reduction of scan backlogs from 28 days to 1-day access. While initially focused on cardiac MRI—the most complex anatomy to image—Vista AI is rapidly expanding its automation platform to other anatomies including brain, prostate, and spine imaging. The company's vision is to make gold-standard MRI universally available through automation, ensuring every patient has access to high-quality imaging regardless of location or technologist expertise. Founded by Stanford-trained experts and guided by leading medical advisors, Vista AI serves health systems, imaging centers, and hospitals seeking to improve throughput, standardize quality, and expand access to advanced MRI services.
Company description HeartVista official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Embedded · On Premise deployment with recorded integration context.
Company milestones
Two-year data release proving faster and more reliable MRI scans (December 2024), Daniel Hawkins appointed as CEO (March 2024), Steve Cashman joined Board of Directors (September 2023)
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
MRI operating system and GUI-based design tools for research imaging applications
FDA-cleared automated cardiac MRI scanning software for all technologists
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Magnetic resonance in medicine · Sep 1, 2022
A metabolite-specific 3D stack-of-spiral bSSFP sequence for improved lactate imaging in hyperpolarized [1-13 C]pyruvate studies on a 3T clinical scanner.Magnetic resonance in medicine · Sep 1, 2020
A regional bolus tracking and real-time B1 calibration method for hyperpolarized 13 C MRI.Magnetic resonance in medicine · Feb 1, 2019
Spectrally selective three-dimensional dynamic balanced steady-state free precession for hyperpolarized C-13 metabolic imaging with spectrally selective radiofrequency pulses.Magnetic resonance in medicine · Sep 1, 2017
Development of high resolution 3D hyperpolarized carbon-13 MR molecular imaging techniques.Magnetic resonance imaging · May 1, 2017
Multiband RF pulses with improved performance via convex optimization.Journal of magnetic resonance (San Diego, Calif. : 1997) · Jan 1, 2016
Clinical validation
No linked records are currently available.
Regulatory
K183274 · 510k · Oct 18, 2019
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Real-world cardiac MRI scanning efficiency
Increased throughput with existing resources
Reduced patient wait times for cardiac MRI
Enhancing MRI workflow efficiency and technologist training for cardiac imaging
Faster scanning with greater confidence and consistency, quicker technologist training, reduced errors, increased productivity and patient access
Increasing access to high-quality cardiac MR imaging across community sites
Improved quality of cardiac MR imaging across the board
MRI research for catheter tracking and real-time analysis of movement
MR-guided EP Ablation research
MR-guided Convection Enhanced Delivery research
Reducing cardiac MRI backlog and improving scan access
26% faster CMR scan times, 50% more scan slots, 1-day CMR access from a 28-day backlog
05 · Leadership
Leadership profiles and professional links from the current Company record.
Daniel Hawkins
President and CEO
Bob Hu
Chief Medical Officer & Co-Founder
Juan Santos
Chief Architect and Head of Research & Co-Founder
William Overall
Chief Technology Officer & Co-Founder
Nicole Winokur
Vice President of Marketing
Sheila Saldana
Vice President of Client Success
06 · Company updates
Recent articles published on HeartVista's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies applying AI to cardiovascular disease detection, ECG/EKG analysis, heart failure management, cardiac imaging, arrhythmia detection, or cardiovascular risk assessment. Includes AI-powered cardiac diagnostics, non-invasive hemodynamic monitoring, and tools for early detection and personalized management of heart conditions.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.